Dr Rajesh Rajput
Director, Endocrinology & Diabetes, Medanta Hospital
-
If Your Diabetes Is Well Controlled On Daily Insulin, Should You Switch To A Once-Weekly Option?
The newly-launched once-weekly basal insulin, Awiqli (insulin icodec by Novo Nordisk) is another therapeutic option that may suit certain individuals better than others
